Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label, Long-term Safety Study of BHV3000 for the Acute Treatment of Migraine in Chinese Subjects

NCT05371652 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05371652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05371652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label, Long-term Safety Study of BHV3000 for the Acute Treatment of Migraine in Chinese Subjects
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
May 19, 2022
Completion date
February 6, 2024
Enrollment
241 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine